The progressive changes in the level of adiponectin and leptin in obese and diabetic conditions that further leads to fatty infiltration shows their applicability as major adipokines in predicting the disease progression towards NAFLD. The gene discussed is ADIPOQ; the disease is metabolic dysfunction-associated steatotic liver disease.